Anticonvulsant Drug Development (ADD) Program people graph sample
-
Peter J. West
Research Associate Professor and Co-investigator at Anticonvulsant Drug Development (Add) Program
Salt Lake City, Utah, United States3 email signals: 1 email signal on utah.edu, 2 non-official email signals7 phone signals available
-
-
Christine Ligouri
Sr. Research Analyst
Sandy, Utah, United States -
Vanja Panic, Phd
Assistant Director, Operations
Salt Lake City Metropolitan Area, United States
How AeroLeads builds company intelligence
Use source-backed company records
AeroLeads combines company source fields, workforce samples, email-pattern aggregates, and related-company records when those signals are available.
Show only available evidence
Blank source fields are omitted. Contact channels are summarized as signals, with raw email addresses and phone numbers masked on public pages.
Compare useful company context
Related company, market, workforce, technology, and management signals help turn a static company listing into a company intelligence page.
Contact research
AeroLeads intelligence
Review reachable contact coverage for Anticonvulsant Drug Development (ADD) Program
AeroLeads maps 1 visible contact signal for Anticonvulsant Drug Development (ADD) Program. Coverage is multi-channel contact coverage.